FDA
approval
· 2017-10-12
FDA Approved: APREPITANT — Original Application (BluePoint Laboratories)
Summary
FDA approved the original application for a generic aprepitant (APREPITANT) from BluePoint Laboratories, confirming a generic version of the antiemetic for its …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for APREPITANT (APREPITANT)